FDA Inspection 1131910 — Quagen Pharmaceuticals LLC

Quagen Pharmaceuticals LLC — FEI 3012403297

The FDA completed an inspection of Quagen Pharmaceuticals LLC on Oct 26, 2020 in West Caldwell, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 26, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
West Caldwell, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.